title: Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.
authors.forename: J
authors.initials: J
authors.lastname: Koskinas
authors.forename: M
authors.initials: M
authors.lastname: Tampaki
authors.forename: P P
authors.initials: PP
authors.lastname: Doumba
authors.forename: E
authors.initials: E
authors.lastname: Rallis
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000209:etiology* / Q000276:immunology; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D000069549:Ustekinumab